EIZO (6737) Q1 2026 earnings summary

Executive summary

• Net sales for Q1 FY2025 were JPY17,338 million, down 4.7% year-over-year, mainly due to economic stagnation in Europe and seasonal demand patterns.

• Operating loss was JPY97 million, a decrease from a profit of JPY57 million in the prior year, impacted by higher SG&A expenses and one-time costs for the new Technology Hub.

• Net income attributable to owners of parent was JPY307 million, down 57.6% year-over-year, with realized FOREX gains of JPY0.1B compared to JPY0.3B in the prior year.

• Gross profit margin improved to 33.7%, up 1.5 percentage points year-over-year, supported by high-value-added products.

• SG&A expenses increased due to higher wages and one-time costs for the new Technology Hub.

Financial highlights

• Net sales: JPY17,338 million (down 4.7% YoY).

• Operating loss: JPY97 million (vs. profit of JPY57 million YoY).

• Ordinary profit: JPY687 million (down 31.6% YoY).

• Profit attributable to owners of parent: JPY307 million (down 57.6% YoY).

• Basic EPS: JPY7.48 (down from JPY17.64 YoY, adjusted for share split).

Outlook and guidance

• Full-year FY2026 forecast: Net sales JPY85,000 million (+5.6% YoY), operating profit JPY4,800 million (+29.5% YoY), ordinary profit JPY6,100 million (+33.9% YoY), profit attributable to owners of parent JPY4,400 million (+6.1% YoY), basic EPS JPY106.90.

• No changes to previously announced forecasts; stronger performance expected in the second half, especially in Healthcare (Japan) and V&S (overseas) markets.

• Capex plans under review with strict control over fixed costs.